טוען...
Design and Sample Size Considerations for Alzheimer’s Disease Prevention Trials Using Multistate Models
BACKGROUND/AIMS: Clinical trials for Alzheimer’s disease (AD) have been aimed primarily at persons who have cognitive symptoms at enrollment. However, researchers are now recognizing that the pathophysiological process of AD begins years if not decades prior to the onset of clinical symptoms. Succes...
שמור ב:
| הוצא לאור ב: | Clin Trials |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442939/ https://ncbi.nlm.nih.gov/pubmed/30922116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774518816323 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|